AORT Artivion Inc shares fall 126 after Q4 2025 EPS lands 40 below consensus analyst estimates FBIOP Fortress posts steep Q4 earnings miss shares slide as preferred investors weigh outlook How Gyre Therapeutics GYRE sensitive is to interest rates Gyre Therapeutics Misses Estimates by 13 RCT RedCloud Holdings plc Ordinary Shares rises 571 percent despite steep Q1 2025 EPS miss that far lags analyst projections